Asensus Surgical, Inc. Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost

Asensus Surgical, Inc. had Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost of $3.12 million as of 2023-12-31, per its 10-K filed 2024-03-21.

Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross › Deferred Tax Assets, Tax Deferred Expense

us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost · last filed 2024-03-21

2023-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $3.12M.
2022-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.84M.
2021-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $2.44M.
2020-12-31: Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost $4.25M.

Period end	Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost	Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost as first filed
2023-12-31	$3.12M 10-K · filed 2024-03-21
2022-12-31	$2.84M 10-K · filed 2024-03-21
2021-12-31	$2.44M 10-K · filed 2023-03-02
2020-12-31	$4.25M 10-K · filed 2022-02-28
2019-12-31	$3.67M 10-K · filed 2021-03-11
2018-12-31	$2.28M 10-K · filed 2020-03-16
2017-12-31	$2.22M 10-K · filed 2019-02-27
2016-12-31	$2.30M 10-K · filed 2018-03-08
2015-12-31	$1.54M 10-K · filed 2017-03-06
2014-12-31	$1.15M 10-K · filed 2016-03-03
2013-12-31	$1.17M 10-K · filed 2015-02-20
2012-12-31	$186.00K 10-K · filed 2014-03-05	$689.00K 10-K · filed 2013-04-01
2011-12-31	$520.00K 10-K · filed 2013-04-01